Circulating IL-6 and CRP are associated with MRI findings in the elderly: The 3C-Dijon Study

Neurology

Volumn 78, Issue 10, 2012, Pages 720-727

  Satizabal, C L ^a,b   Zhu, Y C ^d   Mazoyer, B ^e,f,g,h   Dufouil, C ^a,c   Tzourio, C ^a,c  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^e Groupe d'Imagerie Neurofonctionnelle   (France)

^f UNIVERSITÉ DE CAEN   (France)

^g CAEN UNIVERSITY HOSPITAL   (France)

^h INSTITUT UNIVERSITAIRE DE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

AGED; ARTICLE; BRAIN INFARCTION; BRAIN SIZE; FEMALE; FOLLOW UP; GRAY MATTER; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; VOXEL BASED MORPHOMETRY; WHITE MATTER;

EID: 84860803323     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318248e50f     Document Type: Article

References (40)

1. Sullivan GW, Sarembock IJ, Linden J. The role of inflammation in vascular diseases. J Leukoc Biol 2000;67:591-602.
2. Amor S, Puentes F, Baker D, van der Valk P. Inflammation in neurodegenerative diseases. Immunology 2010; 129:154-169.
3. Muir KW, Tyrrell P, Sattar N, Warburton E. Inflammation and ischaemic stroke. Curr Opin Neurol 2007;20: 334-342. (Pubitemid 46743118)
4. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: A risk profile from the Framingham Study. Stroke 1991;22:312-318.
5. Jeerakathil T, Wolf PA, Beiser A, et al. Stroke risk profile predicts white matter hyperintensity volume: The Framingham Study. Stroke 2004;35:1857-1861. (Pubitemid 38971865)
6. Das RR, Seshadri S, Beiser AS, et al. Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study. Stroke 2008;39:2929-2935.
7. Seshadri S, Wolf PA, Beiser A, et al. Stroke risk profile, brain volume, and cognitive function: The Framingham Offspring Study. Neurology 2004;63:1591-1599. (Pubitemid 39507574)
8. Baune BT, Ponath G, Rothermundt M, Roesler A, Berger K. Association between cytokines and cerebral MRI changes in the aging brain. J Geriatr Psychiatry Neurol 2009;22:23-34.
9. Fornage M, Chiang YA, O'Meara ES, et al. Biomarkers of inflammation and MRI-defined small vessel disease of the brain: The Cardiovascular Health Study. Stroke 2008;39: 1952-1959.
10. Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relations of serum high-sensitivity C-reactive protein and interleukin-6 levels with silent brain infarction. Stroke 2005;36:768-772.
11. Schmidt R, Schmidt H, Pichler M, et al. C-reactive protein, carotid atherosclerosis, and cerebral small-vessel disease: Results of the Austrian Stroke Prevention Study. Stroke 2006;37:2910-2916. (Pubitemid 44913857)
12. van Dijk EJ, Prins ND, Vermeer SE, et al. C-reactive protein and cerebral small-vessel disease: The Rotterdam Scan Study. Circulation 2005;112:900-905. (Pubitemid 41170078)
13. Wada M, Nagasawa H, Kurita K, et al. Cerebral small vessel disease and C-reactive protein: Results of a crosssectional study in community-based Japanese elderly. J Neurol Sci 2008;264:43-49. (Pubitemid 350184068)
14. Wright CB, Moon Y, Paik MC, et al. Inflammatory biomarkers of vascular risk as correlates of leukoariosis. Stroke 2009;40:3466-3471.
15. Jefferson AL, Massaro JM, Wolf PA, et al. Inflammatory biomarkers are associated with total brain volume: The Framingham Heart Study. Neurology 2007;68:1032-1038. (Pubitemid 46569138)
16. Vascular factors and risk of dementia: Design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 2003;22:316-325.
17. Maillard P, Delcroix N, Crivello F, et al. An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases. Neuroradiology 2008;50:31-42.
18. DeCarli C, Fletcher E, Ramey V, Harvey D, Jagust WJ. Anatomical mapping of white matter hyperintensities (WMH): Exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005;36:50-55. (Pubitemid 40054174)
19. Zhu YC, Tzourio C, Soumare A, Mazoyer B, Dufouil C, Chabriat H. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: A population-based study. Stroke 2010;41:2483-2490.
20. Lemaitre H, Crivello F, Grassiot B, Alperovitch A, Tzourio C, Mazoyer B. Age-and sex-related effects on the neuroanatomy of healthy elderly. Neuroimage 2005;26:900-911. (Pubitemid 40825032)
21. Dufouil C, Richard F, Fievet N, et al. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: The Three-City Study. Neurology 2005;64:1531-1538. (Pubitemid 40617688)
22. Wersching H, Duning T, Lohmann H, et al. Serum C-reactive protein is linked to cerebral microstructural integrity and cognitive function. Neurology 2010;74:1022-1029.
23. Lim JS, Kwon HM. Risk of "silent stroke" in patients older than 60 years: Risk assessment and clinical perspectives. Clin Interv Aging 2010;5:239-251.
24. Zhu YC, Dufouil C, Tzourio C, Chabriat H. Silent brain infarcts: A review of MRI diagnostic criteria. Stroke 2011; 42:1140-1145.
25. Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly persons. Biol Psychiatry 2008;64:273-280.
26. Moody DM, Brown WR, Challa VR, Ghazi-Birry HS, Reboussin DM. Cerebral microvascular alterations in aging, leukoaraiosis, and Alzheimer's disease. Ann NY Acad Sci 1997;826:103-116. (Pubitemid 27478034)
27. ten Dam VH, van den Heuvel DM, de Craen AJ, et al. Decline in total cerebral blood flow is linked with increase in periventricular but not deep white matter hyperintensities. Radiology 2007;243:198-203. (Pubitemid 46579711)
28. Farrall AJ, Wardlaw JM. Blood-brain barrier: Ageing and microvascular disease: Systematic review and meta-analysis. Neurobiol Aging 2009;30:337-352.
29. Simpson JE, Fernando MS, Clark L, et al. White matter lesions in an unselected cohort of the elderly: Astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol Appl Neurobiol 2007;33:410-419. (Pubitemid 47037889)
30. Simpson JE, Ince PG, Higham CE, et al. Microglial activation in white matter lesions and nonlesional white matter of ageing brains. Neuropathol Appl Neurobiol 2007;33: 670-683. (Pubitemid 350076092)
31. DeCarli C, Massaro J, Harvey D, et al. Measures of brain morphology and infarction in the Framingham Heart Study: Establishing what is normal. Neurobiol Aging 2005; 26:491-510. (Pubitemid 40093933)
32. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults. Biol Psychiatry 2008;64:484-490.
33. Karas GB, Scheltens P, Rombouts SA, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004;23:708-716. (Pubitemid 39370621)
34. Apostolova LG, Thompson PM. Mapping progressive brain structural changes in early Alzheimer's disease and mild cognitive impairment. Neuropsychologia 2008;46: 1597-1612.
35. Gorelick PB. Role of inflammation in cognitive impairment: Results of observational epidemiological studies and clinical trials. Ann NY Acad Sci 2010;1207:155-162.
36. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol 2010;120:287-296.
37. Schwab C, McGeer PL. Inflammatory aspects of Alzheimer disease and other neurodegenerative disorders. J Alzheimers Dis 2008;13:359-369. (Pubitemid 352039027)
38. Spooren A, Kolmus K, Laureys G, et al. Interleukin-6, a mental cytokine. Brain Res Rev 2011;67:157-183.
39. Schmidt R, Ropele S, Enzinger C, et al. White matter lesion progression, brain atrophy, and cognitive decline: The Austrian Stroke Prevention Study. Ann Neurol 2005;58: 610-616. (Pubitemid 41377225)
40. Godin O, Maillard P, Crivello F, et al. Association of white-matter lesions with brain atrophy markers: The three-city Dijon MRI study. Cerebrovasc Dis 2009;28: 177-184.